KPTI logo

Karyopharm Therapeutics (KPTI) EV/EBITDA

EV/EBITDA

-3.70
+0.03+0.80%

Fri, 07 Feb 2025 22:48:20 GMT


Summary


Performance

KPTI EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherKPTIvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

KPTI EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+0.8%-0.9%-2.2%
1 m1 month+9.8%-9.8%-21.5%
3 m3 months+14.8%-14.8%-30.5%
6 m6 months-7.6%-6.0%-23.1%
ytdytd+2.6%-2.7%-6.5%
1 y1 year-47.4%-32.3%-57.6%
5 y5 years+39.8%-82.1%-96.3%

KPTI EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-1.4%-4.10+9.8%
3 m3-month-3.65-1.4%-4.35+14.9%
6 m6-month-3.17-16.7%-4.58+19.2%
1 y1-year-2.14-72.9%-4.58+19.2%
3 y3-year-1.74-112.6%-11.13+66.8%
5 y5-year-1.74-112.6%-11.13+66.8%
alltimeall time-1.12-230.4%-33.48+89.0%

Karyopharm Therapeutics EV/EBITDA History

DateValue
2025
-3.70(-2.6%)
2024
-3.80(+102.1%)
2023
-1.88(-39.2%)
2022
-3.09(-37.2%)
2021
-4.92(-30.6%)
2020
-7.09(+3.8%)
DateValue
2019
-6.83(+115.5%)
2018
-3.17(0.0%)
2017
-3.17(+0.3%)
2016
-3.16(-10.2%)
2015
-3.52(-75.2%)
2014
-14.22(-8.0%)
2013
-15.45

FAQ

  • What is Karyopharm Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Karyopharm Therapeutics?
  • What is KPTI EV/EBITDA year-to-date change?
  • What is Karyopharm Therapeutics EV/EBITDA year-on-year change?

What is Karyopharm Therapeutics EV/EBITDA?

The current EV/EBITDA of KPTI is -3.70

What is the all time high EV/EBITDA for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high EV/EBITDA is -1.12

What is KPTI EV/EBITDA year-to-date change?

Karyopharm Therapeutics EV/EBITDA has changed by +0.10 (+2.63%) since the beginning of the year

What is Karyopharm Therapeutics EV/EBITDA year-on-year change?

Over the past year, KPTI EV/EBITDA has changed by -1.19 (-47.41%)